Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness PK Parida, M Marquez-Palencia, V Nair, AK Kaushik, K Kim, J Sudderth, ... Cell metabolism 34 (1), 90-105. e7, 2022 | 45 | 2022 |
Determinants of renal cell carcinoma invasion and metastatic competence K Kim, Q Zhou, A Christie, C Stevens, Y Ma, O Onabolu, S Chintalapati, ... Nature communications 12 (1), 5760, 2021 | 32 | 2021 |
Metastatic latency, a veiled threat K Kim, M Marquez-Palencia, S Malladi Frontiers in immunology 10, 472463, 2019 | 23 | 2019 |
Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases PK Parida, M Marquez-Palencia, S Ghosh, N Khandelwal, K Kim, V Nair, ... Nature Cancer 4 (6), 893-907, 2023 | 9 | 2023 |
Cell competition shapes metastatic latency and relapse K Kim, H Huang, PK Parida, L He, M Marquez-Palencia, TC Reese, ... Cancer discovery 13 (1), 85-97, 2023 | 8 | 2023 |
Optimized protocol for stable isotope tracing and steady-state metabolomics in mouse HER2+ breast cancer brain metastasis PK Parida, M Marquez-Palencia, AK Kaushik, K Kim, V Nair, J Sudderth, ... STAR protocols 3 (2), 101345, 2022 | 1 | 2022 |
AXL/WRNIP1 mediates replication stress response and promotes therapy resistance and metachronous metastasis in HER2+ breast cancer M Marquez-Palencia, L Reza Herrera, PK Parida, S Ghosh, K Kim, ... Cancer Research 84 (5), 675-687, 2024 | | 2024 |
AXL-WRNIP1 mediated replication stress response aids metastatic latency and relapse M Marquez-Palencia, S Malladi Cancer Research 83 (7_Supplement), 2462-2462, 2023 | | 2023 |
Abstract PD4-07: Targeting latent residual HER2+ breast cancer brain metastatic cells M Marquez-Palencia, S Malladi Cancer Research 82 (4_Supplement), PD4-07-PD4-07, 2022 | | 2022 |